Literature DB >> 7685521

Thy-1-expressing CD34+ human cells express multiple hematopoietic potentialities in vitro and in SCID-hu mice.

B Péault1, I L Weissman, A M Buckle, A Tsukamoto, C Baum.   

Abstract

We have detected a minor subset of fetal liver and bone marrow CD34+ cells that coexpress the Thy-1 antigen at their surface. In immune-deficient SCID mice engrafted with human fetal hematopoietic tissues, CD34+ Thy-1+ reconstitute the full range of thymic lymphocytes and yield a progeny of myeloid and B cells in the human bone marrow. The frequency of cells initiating long-term human myeloid and B lymphocytes in vitro cultures at the contact of the Sys-1 stromal cell line was also found to be 10-15 times higher among CD34+ Thy-1+ cells than in the Thy-1- counterpart population. We propose that CD34+ Thy-1+ cells include candidate human hematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685521

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  10 in total

1.  Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome.

Authors:  R Vargas-Poussou; D Feldmann; M Vollmer; M Konrad; L Kelly; L P van den Heuvel; L Tebourbi; M Brandis; L Karolyi; S C Hebert; H H Lemmink; G Deschênes; F Hildebrandt; H W Seyberth; L M Guay-Woodford; N V Knoers; C Antignac
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Engraftment and lineage potential of adult hematopoietic stem and progenitor cells is compromised following short-term culture in the presence of an aryl hydrocarbon receptor antagonist.

Authors:  Angel Gu; Monica Torres-Coronado; Chy-Anh Tran; Hieu Vu; Elizabeth W Epps; Janet Chung; Nancy Gonzalez; Suzette Blanchard; David L DiGiusto
Journal:  Hum Gene Ther Methods       Date:  2014-08       Impact factor: 2.396

3.  Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age.

Authors:  Wendy W Pang; Elizabeth A Price; Debashis Sahoo; Isabel Beerman; William J Maloney; Derrick J Rossi; Stanley L Schrier; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

4.  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation.

Authors:  Catriona H M Jamieson; Jason Gotlib; Jeffrey A Durocher; Mark P Chao; M Rajan Mariappan; Marla Lay; Carol Jones; James L Zehnder; Stan L Lilleberg; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

5.  Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice.

Authors:  Wendy W Pang; Agnieszka Czechowicz; Aaron C Logan; Rashmi Bhardwaj; Jessica Poyser; Christopher Y Park; Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2019-02-11       Impact factor: 25.476

6.  Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

Authors:  Wendy W Pang; John V Pluvinage; Elizabeth A Price; Kunju Sridhar; Daniel A Arber; Peter L Greenberg; Stanley L Schrier; Christopher Y Park; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

7.  The Role of MicroRNAs in Hematopoietic Stem Cell and Leukemic Stem Cell Function.

Authors:  Stephen S Chung; Wenhuo Hu; Christopher Y Park
Journal:  Ther Adv Hematol       Date:  2011-10

8.  Heterogeneous Niche Activity of Ex-Vivo Expanded MSCs as Factor for Variable Outcomes in Hematopoietic Recovery.

Authors:  Jung-Ho Kim; Ho-Sun Lee; Hyun-Kyung Choi; Jin-A Kim; In-Sun Chu; Sun-Hee Leem; Il-Hoan Oh
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

9.  Shift of EMT gradient in 3D spheroid MSCs for activation of mesenchymal niche function.

Authors:  Sohee Jeon; Ho-Sun Lee; Ga-Young Lee; Gyeongsin Park; Tae-Min Kim; Jihye Shin; Cheolju Lee; Il-Hoan Oh
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

10.  Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma.

Authors:  Hae-Ri Lee; Ga-Young Lee; Eung-Won Kim; Hee-Je Kim; Minho Lee; R Keith Humphries; Il-Hoan Oh
Journal:  Haematologica       Date:  2022-02-01       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.